Japan approves drug as treatment for COVID-19


TOKYO: Japan on Thursday approved Gilead Sciences? remdesivir as a treatment for COVID-19, making it the country’s first officially authorized drug to tackle the coronavirus disease. Japan reached the decision just three days after the U.S. drugmaker filed for fast-track approval for the treatment. “There has so far been no coronavirus medicine available here so it is a significant step for us to approve this drug,” a Japanese health ministry official said at a press briefing.